# Photodynamic Therapy With Metil 5-aminolevulinate for Actinic Cheilitis - Phase 2 Clinical Trial

> **NCT03990636** · PHASE2 · UNKNOWN · sponsor: **Instituto Nacional de Cancer, Brazil** · enrollment: 40 (estimated)

## Conditions studied

- Actinic Cheilitis
- Leukoplakia
- Erythroplakia

## Interventions

- **DRUG:** Metil 5-aminolevulinate

## Key facts

- **NCT ID:** NCT03990636
- **Lead sponsor:** Instituto Nacional de Cancer, Brazil
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-17
- **Primary completion:** 2020-05-15
- **Final completion:** 2021-12-15
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2019-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03990636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03990636, "Photodynamic Therapy With Metil 5-aminolevulinate for Actinic Cheilitis - Phase 2 Clinical Trial". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03990636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*